Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Korean researchers report development of potent angiotensin II antagonists

Nov. 22, 1999

Collateral Therapeutics succeeds in developing a double-barreled gene therapy for CV disease

Nov. 22, 1999

Human pharmacokinetics of OPC-41061 reported at 1999 AAPS

Nov. 19, 1999

Tezosentan is safe and produces beneficial vasodilatory responses in patients with CHF

Nov. 18, 1999

Bosentan safe and effective in CHF during open-label extension of REACH-1

Nov. 18, 1999

Pharmacokinetic profiles of two oral AII antagonists described by Pfizer at AAPS

Nov. 18, 1999

AVI BioPharma files IND with FDA for Resten-NG

Nov. 18, 1999

Cardiovascular and renal agents from SB act as endothelin antagonists

Nov. 16, 1999

Cardioprotective ginkgolides under study at CNRS

Nov. 16, 1999

Favorable phase II results announced for Valentis's VEGF165 gene medicine at AHA

Nov. 15, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...